Astrivax Therapeutics

This early-stage study tested two new vaccines—one for yellow fever and one for rabies—in 112 healthy adults aged 18 to 40. The main goal was to check if the vaccines are safe and how well they trigger an immune response. Participants received either the vaccine or a placebo, and…